Cargando…
Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 & 2 and AMP-activated Protein Kinase in the Kidney
The type-2 diabetes drug metformin has proven to have protective effects in several renal disease models. Here, we investigated the protective effects in a 3-day unilateral ureteral obstruction (3dUUO) mouse model. Compared with controls, ureteral obstructed animals displayed increased tubular damag...
Autores principales: | Christensen, Michael, Jensen, Jonas B., Jakobsen, Steen, Jessen, Niels, Frøkiær, Jørgen, Kemp, Bruce E., Marciszyn, Allison L., Li, Hui, Pastor-Soler, Núria M., Hallows, Kenneth R., Nørregaard, Rikke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080611/ https://www.ncbi.nlm.nih.gov/pubmed/27782167 http://dx.doi.org/10.1038/srep35952 |
Ejemplares similares
-
Renal PET-imaging with (11)C-metformin in a transgenic mouse model for chronic kidney disease
por: Pedersen, Lea, et al.
Publicado: (2016) -
Results from (11)C-metformin-PET scans, tissue analysis and cellular drug-sensitivity assays questions the view that biguanides affects tumor respiration directly
por: Iversen, Ane B., et al.
Publicado: (2017) -
Renoprotective effects of metformin
por: Nasri, Running Hamid
Publicado: (2013) -
Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney
por: Nørregaard, Rikke, et al.
Publicado: (2015) -
Resveratrol Inhibits the Epithelial Sodium Channel via Phopshoinositides and AMP-Activated Protein Kinase in Kidney Collecting Duct Cells
por: Weixel, Kelly M., et al.
Publicado: (2013)